Literature DB >> 10369768

Topology of Xer recombination on catenanes produced by lambda integrase.

J Bath1, D J Sherratt, S D Colloms.   

Abstract

Xer site-specific recombination at the psi site from plasmid pSC101 displays topological selectivity, such that recombination normally occurs only between directly repeated sites on the same circular DNA molecule. This intramolecular selectivity is important for the biological role of psi, and is imposed by accessory proteins PepA and ArcA acting at accessory DNA sequences adjacent to the core recombination site. Here we show that the selectivity for intramolecular recombination at psi can be bypassed in multiply interlinked catenanes. Xer site-specific recombination occurred relatively efficiently between antiparallel psi sites located on separate rings of right-handed torus catenanes containing six or more nodes. This recombination introduced one additional node into the catenanes. Antiparallel sites on four-noded right-handed catenanes, the normal product of Xer recombination at psi, were not recombined efficiently. Furthermore, parallel psi sites on right-handed torus catenanes were not substrates for Xer recombination. These findings support a model in which psi sites are plectonemically interwrapped, trapping a precise number of supercoils that are converted to four catenation nodes by Xer strand exchange. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10369768     DOI: 10.1006/jmbi.1999.2804

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  2 in total

1.  Decatenation of DNA circles by FtsK-dependent Xer site-specific recombination.

Authors:  Stephen C Y Ip; Migena Bregu; François-Xavier Barre; David J Sherratt
Journal:  EMBO J       Date:  2003-12-01       Impact factor: 11.598

2.  Accessory factors determine the order of strand exchange in Xer recombination at psi.

Authors:  Migena Bregu; David J Sherratt; Sean D Colloms
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.